Pharma Focus Asia
KP - Sustainable Packaging Solutions

Allergan Expands its Dublin and Co Mayo Manufacturing Facilities Investing USD$45m

Introduction:

Botox maker Allergan has announced an addition USD$45m in its Irish Operations. This helps to expand existing manufacturing capacity in Dublin and Co Mayo.

Features:

The additional money will be invested in Allergen’s manufacturing facilities in Westport and Clonshaugh and will support increased manufacturing capabilities for current and future products.

In addition, the Westport facility produces Botox and Allergan’s range of eyecare products, while Clonshaugh in Dublin manufactures the company’s tablet-based medicines.

This continued investment in Ireland operations help to provide innovative medicines to patients across the globe.

Allergan had also made a significant contribution to making Ireland home to a world-class pharmaceutical industry.

With Allergan registered in Ireland, the tax benefit of such a deal was seen as a major motivator for Pfizer. Allergan has made a significant contribution to the economy over its four decades, with investments estimated at a cumulative US$662 m.

Specifications:

NameAllergan
LocationDublin and Co Mayo
TypeExpansion
Estimated CostUS$45m
Parties InvolvedAllergan, Pfizer
Latest Issue
Get instant
access to our latest e-book
Standard BioTools™MFA + MMA 2024Gibco Adherent Kidney Media PanelTFS - ODW - The Technology Debate: Single-Use vs. Stainless SteelAsia Healthcare Week 2024CPHI Korea 2024CHEMICAL INDONESIA 2024Thermofisher - Antibody Therapeutic PolishingINALAB 20244th Middle East Pharmacoeconomics and Drug Policy Summit 2024Digital Health Asia 2024Rehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference
Searching for an end-to-end patient tech solution?